MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 73 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,099 | -99.8% | 193 | -99.8% | 0.00% | -100.0% |
| Q2 2023 | $2,862,412 | +193.8% | 110,646 | +172.8% | 0.00% | – |
| Q1 2023 | $974,395 | -53.4% | 40,566 | -62.1% | 0.00% | -100.0% |
| Q4 2022 | $2,088,763 | +452.6% | 107,116 | +495.9% | 0.00% | – |
| Q3 2022 | $378,000 | +869.2% | 17,977 | +624.6% | 0.00% | – |
| Q4 2021 | $39,000 | +160.0% | 2,481 | +229.0% | 0.00% | – |
| Q3 2021 | $15,000 | -34.8% | 754 | -35.1% | 0.00% | – |
| Q1 2021 | $23,000 | -90.9% | 1,161 | -92.0% | 0.00% | – |
| Q4 2020 | $254,000 | -8.3% | 14,554 | +1.4% | 0.00% | – |
| Q3 2020 | $277,000 | -9.8% | 14,349 | -9.2% | 0.00% | – |
| Q2 2020 | $307,000 | +29.0% | 15,797 | -7.1% | 0.00% | – |
| Q1 2020 | $238,000 | +101.7% | 17,000 | +252.9% | 0.00% | – |
| Q4 2019 | $118,000 | +227.8% | 4,817 | +34.3% | 0.00% | – |
| Q3 2019 | $36,000 | – | 3,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |